Potential therapeutic approach for the hormonal treatment of lacrimal gland dysfunction in Sjögren's syndrome
- 1 July 1992
- journal article
- review article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 64 (1) , 9-16
- https://doi.org/10.1016/0090-1229(92)90052-p
Abstract
No abstract availableThis publication has 81 references indexed in Scilit:
- Gravidin, an endogenous inhibitor of phospholipase A2 activity, is a secretory component of IgABiochemical and Biophysical Research Communications, 1991
- Androgen control of autoimmune expression in lacrimal glands of miceClinical Immunology and Immunopathology, 1989
- Influence of the hypothalamic-pituitary axis on the androgen regulation of the ocular secretory immune systemJournal of Steroid Biochemistry, 1988
- The effect of danazol in the MRL/lpr mouse model of autoimmune diseaseInflammation Research, 1988
- Hormone control of autoantibodies to calf thymus nuclear extract (CTE) and DNA in MRL-lpr and MRL-+/+ miceClinical Immunology and Immunopathology, 1988
- Immunohistochemical characterization of sialadenitis in NZB × NZW F1 miceClinical Immunology and Immunopathology, 1987
- Post‐mortem prevalence of lymphocytic infiltration of the lacrymal gland: A comparative study in autoimmune and non‐autoimmune diseasesThe Journal of Pathology, 1984
- Danazol for the Treatment of Idiopathic Thrombocytopenic PurpuraNew England Journal of Medicine, 1983
- Persistent Cytomegalovirus infection—The etiology of Sjogren's SyndromeMedical Hypotheses, 1983
- Effects of castration and sex hormones on immune clearance and autoimmune disease in and miceClinical Immunology and Immunopathology, 1983